Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$8.84 - $22.64 $2.72 Million - $6.96 Million
-307,229 Reduced 58.03%
222,159 $3.11 Million
Q1 2020

Aug 14, 2020

BUY
$13.68 - $34.6 $7.11 Million - $18 Million
519,944 Added 5505.55%
529,388 $9.44 Million
Q1 2020

May 15, 2020

SELL
$13.68 - $34.6 $112,476 - $284,481
-8,222 Reduced 46.54%
9,444 $168,000
Q4 2019

Feb 13, 2020

SELL
$21.11 - $34.86 $10.8 Million - $17.8 Million
-511,722 Reduced 96.66%
17,666 $589,000
Q3 2019

Nov 12, 2019

SELL
$23.83 - $36.44 $581,213 - $888,771
-24,390 Reduced 4.4%
529,388 $12.6 Million
Q2 2019

Aug 13, 2019

SELL
$32.75 - $40.35 $39,169 - $48,258
-1,196 Reduced 0.22%
553,778 $19.9 Million
Q1 2019

May 14, 2019

BUY
$35.47 - $54.55 $5.52 Million - $8.49 Million
155,712 Added 39.0%
554,974 $20.5 Million
Q4 2018

Feb 14, 2019

BUY
$38.35 - $50.39 $3.42 Million - $4.5 Million
89,262 Added 28.79%
399,262 $17.2 Million
Q2 2018

Aug 08, 2018

BUY
$48.35 - $65.33 $1.28 Million - $1.73 Million
26,500 Added 9.35%
310,000 $15.4 Million
Q1 2018

May 02, 2018

BUY
$38.64 - $57.54 $10.8 Million - $16.1 Million
279,039 Added 6255.08%
283,500 $14.1 Million
Q4 2017

Feb 13, 2018

BUY
$27.28 - $43.26 $121,696 - $192,982
4,461
4,461 $166,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $284M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.